ANL 10.41 Decreased By ▼ -0.73 (-6.55%)
ASC 9.21 Decreased By ▼ -0.34 (-3.56%)
ASL 11.77 Decreased By ▼ -0.88 (-6.96%)
AVN 76.05 Decreased By ▼ -2.65 (-3.37%)
BOP 5.49 Decreased By ▼ -0.19 (-3.35%)
CNERGY 5.37 Decreased By ▼ -0.41 (-7.09%)
FFL 6.71 Decreased By ▼ -0.29 (-4.14%)
FNEL 5.93 Decreased By ▼ -0.23 (-3.73%)
GGGL 11.30 Decreased By ▼ -0.80 (-6.61%)
GGL 16.50 Decreased By ▼ -1.30 (-7.3%)
GTECH 8.53 Decreased By ▼ -0.63 (-6.88%)
HUMNL 7.22 Decreased By ▼ -0.38 (-5%)
KEL 2.87 Increased By ▲ 0.03 (1.06%)
KOSM 3.10 Decreased By ▼ -0.18 (-5.49%)
MLCF 25.99 Decreased By ▼ -1.81 (-6.51%)
PACE 3.15 Decreased By ▼ -0.13 (-3.96%)
PIBTL 6.04 Decreased By ▼ -0.45 (-6.93%)
PRL 18.15 Decreased By ▼ -1.36 (-6.97%)
PTC 7.01 Decreased By ▼ -0.22 (-3.04%)
SILK 1.17 Decreased By ▼ -0.09 (-7.14%)
SNGP 33.25 Decreased By ▼ -0.60 (-1.77%)
TELE 11.12 Decreased By ▼ -0.45 (-3.89%)
TPL 9.22 Decreased By ▼ -0.82 (-8.17%)
TPLP 20.17 Decreased By ▼ -1.44 (-6.66%)
TREET 28.70 Decreased By ▼ -1.50 (-4.97%)
TRG 75.75 Decreased By ▼ -2.45 (-3.13%)
UNITY 20.28 Decreased By ▼ -0.91 (-4.29%)
WAVES 12.60 Decreased By ▼ -0.88 (-6.53%)
WTL 1.45 Decreased By ▼ -0.02 (-1.36%)
YOUW 4.75 Decreased By ▼ -0.35 (-6.86%)
BR100 4,083 Decreased By -179.3 (-4.21%)
BR30 14,985 Decreased By -647.2 (-4.14%)
KSE100 41,052 Decreased By -1665.2 (-3.9%)
KSE30 15,662 Decreased By -690.8 (-4.22%)
Pakistan

DRAP permits clinical trials of plasma therapy for Coronavirus treatment: Zafar Mirza

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ve
09 Apr, 2020
  • The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.
  • More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.
  • The companies will prepare quality sanitizers as per the directions of the World Health Organization.

ISLAMABAD: Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza Thursday announced that Drug Regulatory Authority of Pakistan (DRAP) has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.

In a statement, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment, Electronic/Radio channel reported.

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.

The companies will prepare quality sanitizers as per the directions of the World Health Organization.

Comments

Comments are closed.